Maxillary Removal and Reinsertion in Pediatric Patients
Authors:
- Mihir R. PatelMPMihir R. Patel
- Paul C. BrysonPBPaul C. Bryson
- Carol G. ShoresCSCarol G. Shores
- Craig F. HartCHCraig F. Hart
- Leigh B. ThorneLTLeigh B. Thorne
- Allison M. DealADAllison M. Deal
- Adam M. ZanationAZAdam M. Zanation
Open Access
- 1 January 2002
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 128 (1) , 590-596
Abstract
The American Cancer Society1 estimated that in 2008 there would be 37 340 new diagnoses of thyroid carcinoma, which constitutes more than 90% of all endocrine cancers and accounts for the highest annual mortality from endocrine cancer.2 The incidence of thyroid cancer has been reported to be increasing at a rate of 3% per year,3 and patients are diagnosed from a much larger group of patients who are initially seen with thyroid nodules investigated on fine-needle aspiration biopsy. For approximately 30 years, fine-needle aspiration has been the least invasive and most efficient initial test for evaluation of solitary thyroid nodules. Although fine-needle aspiration excels at identifying papillary thyroid carcinoma (PTC), a major deficiency of this diagnostic procedure is that follicular adenoma (FA), follicular thyroid carcinoma (FTC), and follicular variant of PTC (FVPTC) cannot be differentiated cytopathologically.4 The morphologic features of follicular lesions exhibit varying degrees of cellular atypia, and the diagnosis of follicular carcinoma is dependent on the finding of capsular or vascular invasion on formal pathologic evaluation.Keywords
This publication has 11 references indexed in Scilit:
- Discrimination of Benign and Malignant Thyroid Nodules by Molecular ProfilingAnnals of Surgery, 2004
- Trefoil factor 3 overexpression in prostatic carcinoma: Prognostic importance using tissue microarraysThe Prostate, 2004
- A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expressionJournal of Clinical Investigation, 2004
- High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomasBritish Journal of Cancer, 2004
- Gene expression in papillary thyroid carcinoma reveals highly consistent profilesProceedings of the National Academy of Sciences, 2001
- Interpretation and Quantification of ImmunostainsAmerican Journal of Surgical Pathology, 2001
- Augmented Intestinal Trefoil Factor (TFF3) and Loss of pS2 (TFF1) Expression Precedes Metaplastic Differentiation of Gastric EpitheliumLaboratory Investigation, 2001
- Trefoil Peptides: A New Family of Gastrointestinal MoleculesDigestion, 1994
- Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomachGastroenterology, 1993
- Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situBiochemical Journal, 1992